Advancements and Projections in the Global Cardiac Rhythm Management Devices Market: Insights, Trends, Opportunities, and Recent Developments< ...

The global cardiovascular devices market, valued at US$72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, ...

Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...

Epicardial pacemaker and defibrillator systems are commonly used in pediatrics, but have a high rate of lead failure. Wound- and lead-related problems and infections are not uncommonly encountered ...

But there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this year by +13.8%. Now it makes sense why the stock has been powering to new ...

JetBlue is adding four new domestic and three international destinations to its schedule for summer flights departing from Boston Logan International Airport.The airline boasts that the seasonal ...

TOKYO -- A disreputable scientific journal used generative AI to create bogus papers, using the names of three Japanese researchers without permission in what is thought to be an instance of ...

Persistent Link: https://ieeexplore.ieee.org/servlet/opac?punumber=6287639 ...

First FDA-Cleared Antibiotic-Eluting BioEnvelope Now Available in U.S. for Implantable Pacemakers, Defibrillators, and Neurostimulators SILVER SPRING, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc ...

I’m still a believer in the story at Boston Scientific, but the valuation situation remains challenging. I do think there’s a credible chance of BSX generating 10% long-term revenue growth and ...